D. Jacobson

Clarissa M Koch, M. LaValley, J. Berk, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Transthyretin Ser6 as a neutral polymorphism in familial amyloidotic polyneuropathy

G. Holmgren, M. Saraiva, J. Buxbaum, 1996 .

Highly Proliferative α-Cell–Related Islet Endocrine Cells in Human Pancreata

J. Kushner, A. Cox, D. Jacobson, 2018, Diabetes.

Epoetin Alfa Versus Darbepoetin Alfa in Chemotherapy-Related Anemia

R. J. Cersosimo, D. Jacobson, 2006, The Annals of pharmacotherapy.

Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.

H. Jahr, K. Sletten, P. Westermark, 1995, Laboratory investigation; a journal of technical methods and pathology.

Transthyretin lie 122 and Cardiac Amyloidosis in African-Americans 2 Case Reports

M. Ittmann, R. Wieczorek, P. Gorevic, 2022 .

Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.

S. Zolla-Pazner, M. Gorny, H. Furneaux, 2003, Cancer research.

Immunosuppression and infection in multiple myeloma.

S. Zolla-Pazner, D. Jacobson, 1986, Seminars in oncology.

Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure

J. Berk, L. Connors, F. Ruberg, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy

R. Petersen, M. Benson, C. Klein, 1998, Neurology.

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

J. Buxbaum, D. Jacobson, G. Gallo, 1997, The New England journal of medicine.

Drop-in, drop-out allele-specific PCR

J. Buxbaum, D. Jacobson, A. Alexander, 2004, Molecular biotechnology.

Echocardiographic abnormalities in transthyretin (TTR) VI22I allele carriers

M. Stedman, D. Gagnon, M. Brophy, 2004 .

Familial amyloid with a transthyretin leucine 33 mutation presenting with ascites

R. Kyle, D. Jacobson, T. J. Myers, 1998, American journal of hematology.

Revised transthyretin Ile 122 allele frequency in African-Americans

S. Ballas, J. Buxbaum, S. Embury, 1996, Human Genetics.

A double‐variant transthyretin allele (SER 6, ILE 33) in the Israeli patient “SKO” with familial amyloidotic polyneuropathy

J. Buxbaum, D. Jacobson, 1994, Human mutation.

A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.

D. Jacobson, 1992, American journal of human genetics.

Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.

W. Rom, N. Dubin, D. Jacobson, 1995, Cancer research.

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa

Scott M. Williams, S. Tishkoff, S. Sirima, 2016, Molecular genetics & genomic medicine.

Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model

Clarissa M Koch, J. Berk, L. Connors, 2017, JAMA cardiology.

Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease.

D. Jacobson, B. J. Fleming, 1984, The American journal of the medical sciences.

Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis.

F. Salvi, D. De Grandis, A. Ferlini, 1998, American journal of medical genetics.

Transthyretin exon 1: To screen or not to screen? A simple solution

D. Jacobson, 1997 .

Restriction fragment analysis confirms the position 33 mutation in transthyretin from an Israeli patient (SKO) with familial amyloidotic polyneuropathy.

J. Buxbaum, D. Jacobson, F. Santiago-Schwartz, 1988, Biochemical and biophysical research communications.

Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer.

D. Jacobson, N. Mills, C. Fishman, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement

Daniel R. Jacobson, D. McFarlin, J. Buxbaum, 1992, Human Genetics.

K-ras Mutations as Molecular Markers of Lung Cancer

D. Jacobson, 1998 .

Familial amyloidosis in one Chinese family: clinical, immunological, and molecular genetic analysis

D. Chang, J. Buxbaum, C. Chou, 1997, Journal of internal medicine.

RAS MUTATIONS IN LUNG CANCER

D. Jacobson, 1999 .

Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African–Americans

J. Buxbaum, D. Jacobson, C. Tagoe, 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Transthyretin V122I in African Americans with congestive heart failure.

P. Lavori, D. Kitzman, B. Greenberg, 2006, Journal of the American College of Cardiology.

Amyloid and Nonfibrillar Deposits in Mice Transgenic for Wild-Type Human Transthyretin: A Possible Model for Senile Systemic Amyloidosis

J. Ghiso, M. Teng, R. Vidal, 2001, Laboratory Investigation.

Transthyretin VAL107, a new variant associated with familial cardiac and neuropathic amyloidosis

M. Gertz, J. Buxbaum, D. Jacobson, 1994, Human mutation.

Mice transgenic for human TTR have the same frequency of renal TTR deposition whether maintained in conventional or specific pathogen free environments

J. Buxbaum, D. Jacobson, G. Gallo, 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

A 58-year-old man with shortness of breath, ascites, and leg edema.

M. Fedor, I. Kronzon, D. Schwartz, 1996, Circulation.

Transthyretin ILE20, a new variant associated with late‐onset cardiac amyloidosis

J. Buxbaum, D. Jacobson, R. Kyle, 1997, Human mutation.

Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA).

D. Jacobson, D R Jacobson, T Moskovits, 1992, PCR methods and applications.

Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA).

D. Jacobson, T. Moskovits, 1992, PCR methods and applications.